- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03293862
Prevention of Fascial Dehiscence With Prophylactic Onlay Mesh in Emergency Laparotomies
April 15, 2019 updated by: Edivaldo Massazo Utiyama, University of Sao Paulo General Hospital
Prevention of Fascial Dehiscence With Prophylactic Onlay Mesh in Emergency Laparotomies: a Randomized Clinical Trial
Facial dehiscence elicit high morbidity and mortality.
This complication may arise in more than 8.5% of high-risk patients.
Addressing risk factors and optimizing surgical technique are guarded as mainstay measures for prevention, but their efficacy is questionable.
The aim of this study is to analyze the influence of using a polypropylene onlay prophylactic mesh on the incidence of fascial dehiscence in emergency surgery and associated complications.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Fascial dehiscence is associated with high morbidity and mortality rates.
It occurs in more than 8.5% of high-risk patients.
Current preventive measures described are control of risk factors and optimization of surgical technique.
Despite that, the incidence of such complication remained stable in the last decades, highlighting the low efficacy of such measures.
Polypropilene onlay mesh has been used to avoid incisional hernias in selected elective patients, and could be useful in the prevention of fascial dehiscence.
In emergency situations, especially in contaminated and infected surgical procedures, safety and efficacy of mesh is controversial.
In this study the investigators aimed to evaluate the influence of polypropilene prophylactic onlay mesh on the incidence of fascial dehiscence in high-risk patients undergoing midline emergency laparotomy.
As secondary outcome, the associated morbidity, including surgical site occurence, will be analyzed.
The study design will be a randomized controlled trial.
Study Type
Interventional
Enrollment (Actual)
145
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São
-
São Paulo, São, Brazil, 05403000
- Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Emergency laparotomy by midline incision
High risk for abdominal wound dehiscence: Risk index** ≥ 4,0 or ≥ 2,2 in combination with at least one of the following: smoking, obesity, malnutrition or malignant neoplasia.
- Risk index is the sum of values associated with high-risk characteristics, based in the risk score for abdominal wall dehiscence published by van Ramshorst et. al. in World Journal of Surgery, 2010 (Rotterdam risk model):
Age category (in years)
- 40-49: 0.4
- 50-59: 0.9
- 60-69: 0.9
- ≥70: 1.1
Male gender: 0.7
Chronic pulmonary disease: 0.7
Ascites: 1.5
Jaundice: 0.5
Anemia: 0.7
Emergency surgery: 0.6
Type of surgery:
- Gallbladder/bile duct 0.7
- Esophagus 1.5
- Gastroduodenum 1.4
- Small bowel 0.9
- Large bowel 1.4
- Vascular 1.3
Exclusion Criteria:
- Non-midline incisions or midline laparotomy measuring less than 1/4 the distance between the xyphoid and the pubis, including laparoscopic surgery.
- Diagnosis of incisional hernia or presence of previous mesh on site.
- Midline laparotomy performed in less than 30 days.
- Pregnancy
- Severe trauma with hemodynamic instability
- Need for open abdomen or relaxing incisions
- Need for re-laparotomy during the first 30 postoperative days, except cases in which an abdominal wall dehiscence was diagnosed.
- Death during the first 30 postoperative days, except cases in which an abdominal wall dehiscence was diagnosed before the event.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Suture group
Patients randomized to this arm will undergo midline laparotomy closure using a PDS 0 continuous suture only, without mesh, aiming a suture length to wound length ratio higher than four.
Randomization occurs after fascial closure.
|
midline fascial closure using uninterrupted PDS 0 suture
|
EXPERIMENTAL: Prophylactic mesh group
Patients randomized to this arm will undergo midline laparotomy closure using a PDS 0 continuous suture aiming a suture length to wound length ratio higher than four AND further polypropilene onlay mesh.
Randomization occurs after fascial closure.
|
midline fascial closure using uninterrupted PDS 0 suture
Placement of onlay polypropilene prophylactic mesh after midline fascial closure.
Placement of a subcutaneous vacuum drainage system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Fascial dehiscence incidence
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Surgical site occurence (SSO) incidence
Time Frame: 30 days or during hospital stay
|
30 days or during hospital stay
|
Surgical site occurrence requiring procedural intervention (SSOPI) incidence
Time Frame: 30 days or during hospital stay
|
30 days or during hospital stay
|
Operative time (minutes),
Time Frame: 30 days
|
30 days
|
Hospital length of stay (days)
Time Frame: 30 days
|
30 days
|
Intensive care unit length of stay (days)
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Gomez Diaz CJ, Rebasa Cladera P, Navarro Soto S, Hidalgo Rosas JM, Luna Aufroy A, Montmany Vioque S, Corredera Cantarin C. [Validation of abdominal wound dehiscence's risk model]. Cir Esp. 2014 Feb;92(2):114-9. doi: 10.1016/j.ciresp.2012.12.008. Epub 2013 May 3. Spanish.
- van Ramshorst GH, Nieuwenhuizen J, Hop WC, Arends P, Boom J, Jeekel J, Lange JF. Abdominal wound dehiscence in adults: development and validation of a risk model. World J Surg. 2010 Jan;34(1):20-7. doi: 10.1007/s00268-009-0277-y.
- Lima HVG, Rasslan R, Novo FCF, Lima TMA, Damous SHB, Bernini CO, Montero EFS, Utiyama EM. Prevention of Fascial Dehiscence with Onlay Prophylactic Mesh in Emergency Laparotomy: A Randomized Clinical Trial. J Am Coll Surg. 2020 Jan;230(1):76-87. doi: 10.1016/j.jamcollsurg.2019.09.010. Epub 2019 Oct 28.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2015
Primary Completion (ACTUAL)
March 1, 2017
Study Completion (ACTUAL)
February 1, 2018
Study Registration Dates
First Submitted
September 20, 2017
First Submitted That Met QC Criteria
September 20, 2017
First Posted (ACTUAL)
September 26, 2017
Study Record Updates
Last Update Posted (ACTUAL)
April 17, 2019
Last Update Submitted That Met QC Criteria
April 15, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024878
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgical Wound Dehiscence
-
St. Borbala HospitalSemmelweis University; Department of Surgery, Jahn Ferend Dél-Pesti Kórház... and other collaboratorsTerminatedSurgical Wound | Surgical Site Infection | Wound Dehiscence, Surgical | Dehiscence of Internal Surgical WoundHungary
-
SeraffixTerminatedDehiscence, Surgical WoundIsrael
-
SeraffixCompletedDehiscence, Surgical WoundIsrael
-
RedDress Ltd.Not yet recruitingDehiscence WoundIsrael
-
ConvaTec Inc.Not yet recruitingSurgical Wound, Recent | Trauma-related Wound | Dehiscence Wound | Surgical Wound LeakUnited States
-
French Medical Institute for Mothers and ChildrenCompletedWound Dehiscence | IncisionAfghanistan
-
Molnlycke Health Care ABSyntactxNot yet recruitingSurgical Wound | Surgical Incision | Surgical Wound Dehiscence | Incision, Surgical | Surgical Wound, Recent
-
University of California, San FranciscoTerminatedPostoperative Complications | Surgical Wound Infection | Surgical Wound DehiscenceUnited States
-
Menoufia UniversityCompletedCesarean Section | Wound Dehiscence
-
McMaster UniversityWestern UniversityNot yet recruitingBreast Cancer | Wound Dehiscence, Surgical
Clinical Trials on Midline Fascial Closure
-
ClinAmygateAswan University HospitalRecruitingCholecystolithiasisEgypt
-
Sohag UniversityCompleted
-
Jessica G PutmanCompletedPain, PostoperativeUnited States
-
Samsun Education and Research HospitalCompletedPain, Postoperative | Hernia Incisional | Cholelithiasis (Without Cholecystitis)Turkey
-
The Cleveland ClinicTerminatedParastomal HerniaUnited States
-
Fernandez ZamoraRecruitingColorectal Cancer | Wound Infection | Incisional HerniaSpain
-
Erasmus Medical CenterElisabeth-TweeSteden Ziekenhuis; Rijnstate Hospital; Groene Hart Ziekenhuis; Red... and other collaboratorsCompletedQuality of Life | Pain | Hernia | Wound Infection | Burst AbdomenNetherlands
-
Sunnybrook Health Sciences CentreNot yet recruitingPregnancy Related | Cesarean Section | Post-operative Pain | Fascial Closure | Surgical Technique
-
San Antonio Military Medical CenterUnknownOpen Abdomen After Damage Control LaparotomyUnited States
-
Christian Medical College and Hospital, Ludhiana...Terminated